Loading...
Tevogen Bio Holdings Inc.
TVGN•NASDAQ
Healthcare
Biotechnology
$1.06
$-0.01(-0.93%)
Tevogen Bio Holdings Inc. (TVGN) Financial Performance & Income Statement Overview
Review Tevogen Bio Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-605625.85%
↓ 605625.85%
Net Income Growth
-20289.72%
↓ 20289.72%
Operating Cash Flow Growth
-771.78%
↓ 771.78%
Operating Margin
-8675.07%
↓ 8675.07%
Gross Margin
24.79%
↑ 24.79%
Net Profit Margin
-8915.92%
↓ 8915.92%
ROE
501.22%
↑ 501.22%
ROIC
740.39%
↑ 740.39%
Tevogen Bio Holdings Inc. (TVGN) Income Statement & Financial Overview
Review Tevogen Bio Holdings Inc.'s (TVGN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $396586.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $198293.00 | $0.00 | $99990.00 | $98303.00 |
| Gross Profit | $198293.00 | $0.00 | -$99990.00 | -$98303.00 |
| Gross Profit Ratio | $0.50 | |||
| R&D Expenses | $2.84M | $3.26M | $4.12M | $20.81M |
| SG&A Expenses | $6.59M | $2.82M | $4.47M | $8.71M |
| Operating Expenses | $9.36M | $6.09M | $8.60M | $29.52M |
| Total Costs & Expenses | $9.56M | $6.09M | $8.60M | $29.52M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $15798.00 | $12459.00 | $0.00 | $155786.00 |
| Depreciation & Amortization | $103547.00 | $218930.00 | $0.00 | $98303.00 |
| EBITDA | -$9.33M | -$5.65M | -$8.60M | $11.52M |
| EBITDA Ratio | -$23.51 | |||
| Operating Income | -$9.36M | -$6.09M | -$8.60M | -$29.52M |
| Operating Income Ratio | -$23.61 | |||
| Other Income/Expenses (Net) | -$81342.00 | $201304.00 | -$1.06M | $40.78M |
| Income Before Tax | -$9.44M | -$5.88M | -$9.66M | $11.26M |
| Income Before Tax Ratio | -$23.81 | |||
| Income Tax Expense | $60000.00 | $0.00 | $0.00 | $48.62M |
| Net Income | -$9.44M | -$5.88M | -$9.66M | $11.26M |
| Net Income Ratio | -$23.81 | |||
| EPS | $0.34 | -$0.03 | -$0.04 | $0.08 |
| Diluted EPS | $0.34 | -$0.03 | -$0.04 | -$0.26 |
| Weighted Avg Shares Outstanding | $177.99M | $170.17M | $154.17M | $137.33M |
| Weighted Avg Shares Outstanding (Diluted) | $177.99M | $170.17M | $154.17M | $142.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan